US Stock MarketDetailed Quotes

ABEO Abeona Therapeutics

Watchlist
  • 4.3100
  • -0.1400-3.15%
Close May 21 16:00 ET
  • 4.4900
  • +0.1800+4.18%
Post 19:16 ET
177.51MMarket Cap-1368P/E (TTM)

Abeona Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-23.79%-14.54M
14.89%-37.01M
34.00%-9.24M
15.39%-5.75M
-14.10%-10.28M
14.20%-11.74M
33.78%-43.48M
53.76%-13.99M
34.28%-6.79M
21.55%-9.01M
Net income from continuing operations
-246.74%-31.58M
-36.51%-54.19M
-132.99%-16.59M
-83.96%-11.84M
-306.49%-16.65M
58.69%-9.11M
53.26%-39.7M
84.75%-7.12M
8.66%-6.43M
73.06%-4.1M
Operating gains losses
863.84%17.3M
218.29%10.68M
189.65%4.23M
136.44%1.11M
400.71%7.61M
-280.77%-2.27M
-413.42%-9.03M
---4.71M
---3.04M
---2.53M
Depreciation and amortization
-18.47%724K
-30.13%3.2M
-28.54%721K
-30.78%751K
-38.83%838K
-20.22%888K
2.53%4.58M
-15.64%1.01M
0.09%1.09M
24.66%1.37M
Other non cash items
1,782.35%286K
-8.99%324K
93.34%-119K
146.46%313K
110.88%147K
-100.50%-17K
105.43%356K
-2,568.66%-1.79M
101.88%127K
-1,058.16%-1.35M
Change In working capital
-39.94%-2.82M
69.65%-1.79M
125.35%1.02M
183.33%2.36M
-101.21%-3.15M
-74.29%-2.01M
67.74%-5.89M
79.11%-4M
-47.88%834K
-3,234.00%-1.57M
-Change in receivables
436.00%252K
-172.58%-2.04M
-102.33%-20K
97.64%3.52M
-93.28%-5.46M
-102.50%-75K
193.73%2.81M
128.63%859K
--1.78M
---2.83M
-Change in prepaid assets
-2.75%-1.23M
-107.94%-155K
-26.30%384K
-51.92%238K
-24.37%422K
-416.36%-1.2M
490.03%1.95M
135.44%521K
19.57%495K
10.50%558K
-Change in payables and accrued expense
-349.47%-1.69M
122.41%2.04M
154.81%2.18M
-18.43%-1.36M
126.50%1.59M
91.97%-376K
41.57%-9.11M
72.93%-3.98M
-196.46%-1.15M
254.97%702K
-Change in other current assets
391.07%163K
-287.20%-234K
-500.00%-138K
---31K
---9K
-137.84%-56K
1,885.71%125K
-243.75%-23K
--0
--0
-Change in other current liabilities
-0.98%-310K
16.43%-1.4M
-1.16%-1.39M
97.97%-6K
--308K
---307K
---1.67M
---1.38M
---296K
--0
Cash from discontinued investing activities
Operating cash flow
-23.79%-14.54M
14.89%-37.01M
34.00%-9.24M
15.39%-5.75M
-14.10%-10.28M
14.20%-11.74M
33.78%-43.48M
53.76%-13.99M
34.28%-6.79M
21.55%-9.01M
Investing cash flow
Cash flow from continuing investing activities
-453.55%-7.82M
100.87%208K
145.59%11.53M
-1,236.63%-18.74M
472.75%5.21M
105.67%2.21M
-136.28%-23.96M
-416.16%-25.29M
-93.84%1.65M
-106.38%-1.4M
Capital expenditure reported
-232.57%-725K
-154.62%-331K
-48.00%-37K
-2,100.00%-44K
---32K
-111.65%-218K
96.87%-130K
99.23%-25K
99.50%-2K
--0
Net PPE purchase and sale
----
-88.24%204K
-88.19%17K
-92.23%8K
----
----
--1.73M
--144K
--103K
----
Net investment purchase and sale
-391.97%-7.09M
101.31%335K
145.45%11.55M
-1,308.46%-18.71M
275.53%5.06M
106.20%2.43M
-136.41%-25.57M
-325.92%-25.41M
-94.30%1.55M
-113.12%-2.89M
Cash from discontinued investing activities
Investing cash flow
-453.55%-7.82M
100.87%208K
145.59%11.53M
-1,236.63%-18.74M
472.75%5.21M
105.67%2.21M
-136.28%-23.96M
-416.16%-25.29M
-93.84%1.65M
-106.38%-1.4M
Financing cash flow
Cash flow from continuing financing activities
636,100.00%25.44M
-14.17%37.06M
-82.54%7.47M
448.48%22.98M
274.99%6.62M
-4K
73.66%43.17M
161.87%42.77M
2,321.39%4.19M
-252.56%-3.78M
Net issuance payments of debt
--20M
----
----
----
----
--0
----
----
----
----
Net common stock issuance
--6.42M
-20.38%37.39M
-81.80%7.79M
448.58%22.98M
--6.62M
--0
95.42%46.96M
161.90%42.77M
12,593.94%4.19M
--0
Net preferred stock issuance
----
--0
--0
--0
----
----
---3.78M
--0
--0
----
Proceeds from stock option exercised by employees
----
-3,540.00%-182K
-3,280.00%-169K
----
----
----
-100.60%-5K
---5K
----
----
Net other financing activities
-24,325.00%-977K
---150K
----
----
---5K
---4K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
636,100.00%25.44M
-14.17%37.06M
-82.54%7.47M
448.48%22.98M
274.99%6.62M
---4K
73.66%43.17M
161.87%42.77M
2,321.39%4.19M
-252.56%-3.78M
Net cash flow
Beginning cash position
1.76%14.81M
-62.52%14.56M
-54.39%5.05M
-45.42%6.56M
-80.86%5.02M
-62.52%14.56M
186.12%38.83M
-75.26%11.07M
-57.29%12.02M
72.03%26.22M
Current changes in cash
132.35%3.09M
101.05%256K
180.17%9.76M
-58.76%-1.51M
110.89%1.55M
24.38%-9.54M
-196.10%-24.27M
158.78%3.48M
-105.74%-953K
-209.90%-14.19M
End cash Position
256.64%17.9M
1.76%14.81M
1.76%14.81M
-54.39%5.05M
-45.42%6.56M
-80.86%5.02M
-62.52%14.56M
-62.52%14.56M
-75.26%11.07M
-57.29%12.02M
Free cash flow
-27.60%-15.26M
14.38%-37.34M
33.85%-9.27M
14.77%-5.79M
-14.46%-10.32M
13.26%-11.96M
37.53%-43.61M
58.16%-14.02M
36.73%-6.79M
21.94%-9.01M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -23.79%-14.54M14.89%-37.01M34.00%-9.24M15.39%-5.75M-14.10%-10.28M14.20%-11.74M33.78%-43.48M53.76%-13.99M34.28%-6.79M21.55%-9.01M
Net income from continuing operations -246.74%-31.58M-36.51%-54.19M-132.99%-16.59M-83.96%-11.84M-306.49%-16.65M58.69%-9.11M53.26%-39.7M84.75%-7.12M8.66%-6.43M73.06%-4.1M
Operating gains losses 863.84%17.3M218.29%10.68M189.65%4.23M136.44%1.11M400.71%7.61M-280.77%-2.27M-413.42%-9.03M---4.71M---3.04M---2.53M
Depreciation and amortization -18.47%724K-30.13%3.2M-28.54%721K-30.78%751K-38.83%838K-20.22%888K2.53%4.58M-15.64%1.01M0.09%1.09M24.66%1.37M
Other non cash items 1,782.35%286K-8.99%324K93.34%-119K146.46%313K110.88%147K-100.50%-17K105.43%356K-2,568.66%-1.79M101.88%127K-1,058.16%-1.35M
Change In working capital -39.94%-2.82M69.65%-1.79M125.35%1.02M183.33%2.36M-101.21%-3.15M-74.29%-2.01M67.74%-5.89M79.11%-4M-47.88%834K-3,234.00%-1.57M
-Change in receivables 436.00%252K-172.58%-2.04M-102.33%-20K97.64%3.52M-93.28%-5.46M-102.50%-75K193.73%2.81M128.63%859K--1.78M---2.83M
-Change in prepaid assets -2.75%-1.23M-107.94%-155K-26.30%384K-51.92%238K-24.37%422K-416.36%-1.2M490.03%1.95M135.44%521K19.57%495K10.50%558K
-Change in payables and accrued expense -349.47%-1.69M122.41%2.04M154.81%2.18M-18.43%-1.36M126.50%1.59M91.97%-376K41.57%-9.11M72.93%-3.98M-196.46%-1.15M254.97%702K
-Change in other current assets 391.07%163K-287.20%-234K-500.00%-138K---31K---9K-137.84%-56K1,885.71%125K-243.75%-23K--0--0
-Change in other current liabilities -0.98%-310K16.43%-1.4M-1.16%-1.39M97.97%-6K--308K---307K---1.67M---1.38M---296K--0
Cash from discontinued investing activities
Operating cash flow -23.79%-14.54M14.89%-37.01M34.00%-9.24M15.39%-5.75M-14.10%-10.28M14.20%-11.74M33.78%-43.48M53.76%-13.99M34.28%-6.79M21.55%-9.01M
Investing cash flow
Cash flow from continuing investing activities -453.55%-7.82M100.87%208K145.59%11.53M-1,236.63%-18.74M472.75%5.21M105.67%2.21M-136.28%-23.96M-416.16%-25.29M-93.84%1.65M-106.38%-1.4M
Capital expenditure reported -232.57%-725K-154.62%-331K-48.00%-37K-2,100.00%-44K---32K-111.65%-218K96.87%-130K99.23%-25K99.50%-2K--0
Net PPE purchase and sale -----88.24%204K-88.19%17K-92.23%8K----------1.73M--144K--103K----
Net investment purchase and sale -391.97%-7.09M101.31%335K145.45%11.55M-1,308.46%-18.71M275.53%5.06M106.20%2.43M-136.41%-25.57M-325.92%-25.41M-94.30%1.55M-113.12%-2.89M
Cash from discontinued investing activities
Investing cash flow -453.55%-7.82M100.87%208K145.59%11.53M-1,236.63%-18.74M472.75%5.21M105.67%2.21M-136.28%-23.96M-416.16%-25.29M-93.84%1.65M-106.38%-1.4M
Financing cash flow
Cash flow from continuing financing activities 636,100.00%25.44M-14.17%37.06M-82.54%7.47M448.48%22.98M274.99%6.62M-4K73.66%43.17M161.87%42.77M2,321.39%4.19M-252.56%-3.78M
Net issuance payments of debt --20M------------------0----------------
Net common stock issuance --6.42M-20.38%37.39M-81.80%7.79M448.58%22.98M--6.62M--095.42%46.96M161.90%42.77M12,593.94%4.19M--0
Net preferred stock issuance ------0--0--0-----------3.78M--0--0----
Proceeds from stock option exercised by employees -----3,540.00%-182K-3,280.00%-169K-------------100.60%-5K---5K--------
Net other financing activities -24,325.00%-977K---150K-----------5K---4K----------------
Cash from discontinued financing activities
Financing cash flow 636,100.00%25.44M-14.17%37.06M-82.54%7.47M448.48%22.98M274.99%6.62M---4K73.66%43.17M161.87%42.77M2,321.39%4.19M-252.56%-3.78M
Net cash flow
Beginning cash position 1.76%14.81M-62.52%14.56M-54.39%5.05M-45.42%6.56M-80.86%5.02M-62.52%14.56M186.12%38.83M-75.26%11.07M-57.29%12.02M72.03%26.22M
Current changes in cash 132.35%3.09M101.05%256K180.17%9.76M-58.76%-1.51M110.89%1.55M24.38%-9.54M-196.10%-24.27M158.78%3.48M-105.74%-953K-209.90%-14.19M
End cash Position 256.64%17.9M1.76%14.81M1.76%14.81M-54.39%5.05M-45.42%6.56M-80.86%5.02M-62.52%14.56M-62.52%14.56M-75.26%11.07M-57.29%12.02M
Free cash flow -27.60%-15.26M14.38%-37.34M33.85%-9.27M14.77%-5.79M-14.46%-10.32M13.26%-11.96M37.53%-43.61M58.16%-14.02M36.73%-6.79M21.94%-9.01M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg